Imatinib mesylate has anti-inflammatory properties ... A group of mice were treated with either 33 mg/kg or 100 mg/kg imatinib (which produced blood levels similar to a mid-range dose in humans ...

Finally, we recognise that the use of imatinib mesylate in the treatment of GIST has evolved since this novel therapy became available, and that the treatment protocol of the trial on which our ...